LOW-DOSE IL-2 THERAPY IN SLE: RESULTS FROM A COMBINED PHASE I/IIA CLINICAL TRIAL

被引：0
|
作者：
Humrich, J. [1 ]
Von Spee-Mayer, C. [2 ]
Siegert, E. [2 ]
Bertolo, M. [2 ]
Rose, A. [2 ]
Abdirama, D. [2 ]
Enghard, P. [3 ]
Hiepe, F. [2 ]
Radbruch, A. [4 ]
Burmester, G. -R. [2 ]
Riemekasten, G. [1 ]
机构：
[1] Univ Hosp Schleswig Holstein, Dept Rheumatol, Campus Lubeck, Lubeck, Germany
[2] Charite Univ Med Berlin, Dept Rheumatol & Clin Immunol, Berlin, Germany
[3] Charite Univ Med Berlin, Dept Nephrol & Intens Care Med, Berlin, Germany
[4] German Rheumatism Res Ctr DRFZ, Berlin, Germany
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2016年 / 34卷 / 04期
关键词：
interleukin-2; regulatory T cell; immunotherapy;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
S7:06
引用
收藏
页码：S13 / S13
页数：1
相关论文
共 50 条
  • [1] Low-Dose IL-2 Therapy in Refractory SLE: Results from Single Center Phase I/IIa Clinical Trial
    Humrich, Jens
    von Spee-Mayer, Caroline
    Siegert, Elise
    Rose, Angelika
    Bertolo, Martina
    Enghard, Philipp
    Hiepe, Falk
    Alexander, Tobias
    Feist, Eugen
    Radbruch, Andreas
    Burmester, Gerd R.
    Riemekasten, Gabriela
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [2] LOW-DOSE IL-2 THERAPY IN REFRACTORY SLE: RESULTS FROM A SINGLE CENTRE PHASE I/IIA CLINICAL TRIAL
    Humrich, Jens Y.
    von Spee-Mayer, Caroline
    Siegert, Elise
    Bertolo, Martina
    Abdirama, Dimas
    Rose, Angelika
    Enghard, Philipp
    Hiepe, Falk
    Alexander, Tobias
    Radbruch, Andreas
    Burmester, Gerd-Ruediger
    Riemekasten, Gabriela
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : A62 - A63
  • [3] LOW-DOSE IL-2 THERAPY IN REFRACTORY SLE: INSIGHTS FROM A PHASE I/IIA CLINICAL TRIAL
    Humrich, J. Y.
    von Spee-Mayer, C.
    Siegert, E.
    Bertolo, M.
    Abdirama, D.
    Rose, A.
    Enghard, P.
    Radbruch, A.
    Burmester, G. R.
    Riemekasten, G.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : A58 - A58
  • [4] LOW-DOSE IL-2 THERAPY IN REFRACTORY SLE: EARLY INSIGHTS FROM A PHASE I/IIA CLINICAL TRIAL
    Humrich, J. Y.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 34 - 34
  • [5] Low-dose IL-2 for SLE
    Thorley, Jennifer
    [J]. LANCET RHEUMATOLOGY, 2019, 1 (03): : E143 - E143
  • [6] Local low-dose IL-2 therapy
    Den Otter, W
    Balemans, L
    Battermann, JJ
    Bernsen, MR
    Cadee, JA
    Dobrowolski, Z
    Everse, LA
    Fiszer-Maliszewska, L
    Gavhumende, R
    De Groot, JW
    De Groot, K
    Hennink, WE
    Hill, FWG
    Jurgenliemp-Schulz, I
    Klein, WR
    Koten, JW
    Maas, RA
    Steerenberg, P
    Stewart, R
    Zembala, M
    [J]. HEPATO-GASTROENTEROLOGY, 1999, 46 : 1280 - 1286
  • [7] Mechanisms of action of low-dose IL-2 restoration therapies in SLE
    Ballesteros-Tato, Andre
    Papillion, Amber
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2019, 61 : 39 - 45
  • [8] Low-dose IL-2 therapy for autoimmune diseases
    Collison J.
    [J]. Nature Reviews Rheumatology, 2019, 15 (1) : 2 - 2
  • [9] Low-Dose IL-2 Therapy in Autoimmune and Rheumatic Diseases
    Grasshoff, Hanna
    Comduehr, Sara
    Monne, Luisa R.
    Mueller, Antje
    Lamprecht, Peter
    Riemekasten, Gabriela
    Humrich, Jens Y.
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [10] Low-Dose Whole Brain Radiation Therapy For Early Alzheimer's Dementia: Early Results From A Phase IIa Trial
    Rogers, C. L.
    Lageman, S.
    Harris, T. J.
    Thomas, T.
    Boling, P.
    Karis, J.
    Shi, J.
    Fontanesi, J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E747 - E747
12345